Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History $9.82 -0.70 (-6.65%) As of 07/11/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aerovate Therapeutics Stock Price Performance The Aerovate Therapeutics (AVTE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 84.50%, with a year-to-date return of -89.41%. In the past month, the stock has increased 41.50%, reflecting recent market activity. As of the latest close, Aerovate Therapeutics traded at $10.52 with a market cap of $304.92 million and volume of 130,839 shares. Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.03%1 Month Performance+41.50%3 Month Performance-89.45%Year-To-Date Performance-89.41%1 Year Performance-84.50% AVTE Stock Chart for Sunday, July, 13, 2025 AVTE Chart by TradingView Aerovate Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$10.51$10.52+0.10%$10.83$10.16130,839 shs$304.92 million07/10/2025$10.45$10.51+0.57%$11.10$10.42378,549 shs$304.63 million07/09/2025$10.45$10.45$11.31$10.38275,629 shs$302.89 million07/08/2025$11.14$10.45-6.19%$11.31$10.38275,629 shs$302.89 million07/07/2025$11.14$11.14$11.33$10.14110,749 shs$322.89 million07/04/2025$10.80$11.14+3.15%$11.33$10.14110,749 shs$322.89 million07/03/2025$9.99$10.80+8.11%$11.28$10.47197,525 shs$313.04 million07/02/2025$9.99$9.99$10.16$8.69535,609 shs$289.56 million07/01/2025$9.19$9.99+8.71%$10.16$8.69535,609 shs$289.56 million06/30/2025$9.19$9.19$9.83$8.614.17 million shs$266.37 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$10.51$9.25-11.99%$10.82$9.10243,265 shs$268.11 million06/26/2025$10.48$10.51+0.29%$10.89$10.13271,204 shs$304.63 million06/25/2025$9.87$10.48+6.18%$10.67$9.33511,893 shs$303.76 million06/24/2025$9.89$9.87-0.20%$10.30$9.44631,787 shs$286.08 million06/23/2025$9.89$9.89$10.09$9.442.14 million shs$286.66 million06/20/2025$9.41$9.41$9.51$7.93886,905 shs$272.75 million06/19/2025$8.29$9.41+13.51%$9.51$7.93886,905 shs$272.75 million06/18/2025$6.99$8.29+18.60%$8.34$6.90517,723 shs$240.29 million06/17/2025$6.76$6.99+3.40%$7.25$6.61327,062 shs$202.61 million06/16/2025$6.76$6.76$7.26$6.57240,117 shs$195.94 million06/13/2025$7.03$6.94-1.28%$7.30$6.87271,750 shs$77.68 million06/12/2025$7.06$7.03-0.42%$7.33$6.96297,915 shs$203.77 million Related Companies CureVac Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Structure Therapeutics Stock Chart Harrow Stock Chart Phibro Animal Health Stock Chart AbCellera Biologics Stock Chart Intellia Therapeutics Stock Chart Amphastar Pharmaceuticals Stock Chart WAVE Life Sciences Stock Chart Aurinia Pharmaceuticals Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
